MedPath

The effect of N-acetyl L-cysteine in Chronic obstructive pulmonary disease

Phase 2
Conditions
Chronic obstructive pulmonary disease.
Other chronic obstructive pulmonary disease
Registration Number
IRCT201509064345N5
Lead Sponsor
Vice chancellor for research of Guilan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age 25 to 60 years old;Ejection fraction more than or equal to 40 percent
Exclusion criteria :Massive blood transfusion; Any complication caused prolongation of operation or intubation

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PULMONARY FUNCTION. Timepoint: Before surgery,5,15,30 days after surgery. Method of measurement: PULMONARY FUNCTION TEST(PFT)/With spirometery/Bionet SPM 300/ south Korea.;Arterial blood gas (ABG). Timepoint: Before and after surgery then every 4 hours in ICU. Method of measurement: blood from an artery intraarterial cannula/convergent.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath